• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理论与实践之间:用于理解 PROTACs 溶解性和脂溶性的计算/实验综合方法。

Between Theory and Practice: Computational/Experimental Integrated Approaches to Understand the Solubility and Lipophilicity of PROTACs.

机构信息

Department of Chemistry, Biology and Biotechnology, University of Perugia, Via dell' Elce di Sotto 8, Perugia 06123, Italy.

Kinetic Business Centre, Molecular Discovery Ltd., Elstree, Borehamwood, Hertfordshire WD6 4PJ, United Kingdom.

出版信息

J Med Chem. 2024 Sep 26;67(18):16355-16380. doi: 10.1021/acs.jmedchem.4c01235. Epub 2024 Sep 13.

DOI:10.1021/acs.jmedchem.4c01235
PMID:39271471
Abstract

Emerging drug candidates more often fall in the beyond-rule-of-five chemical space. Among them, proteolysis targeting chimeras (PROTACs) have gained great attention in the past decade. Although physicochemical properties of small molecules accomplishing Lipinski's rule-of-five can now be easily predicted through models generated by large data collections, for PROTACs the knowledge is still limited and heterogeneous, hampering their prediction. Here, the kinetic solubility and the coefficient of distribution at pH 7.4 (LogD) of 44 PROTACs, designed and synthesized to cover a wide chemical space, were measured. Their generally low solubility and high lipophilicity required an optimization of the experimental methods. Concerning the LogD, several prediction tools were tested, which were quite accurate for classical small molecules but provided dissimilar outcomes for PROTACs. Finally, models for the prediction of PROTACs' kinetic solubility and LogD were proposed by combining in-house generated experimental data with 3D description of PROTACs' structures.

摘要

新兴的药物候选物往往属于超出“五规则”的化学空间。在这些候选物中,蛋白水解靶向嵌合体(PROTACs)在过去十年中受到了极大关注。尽管通过大型数据集生成的模型,现在可以轻松预测满足“五规则”的小分子的物理化学性质,但对于 PROTACs,相关知识仍然有限且存在差异,阻碍了其预测。在这里,我们测量了 44 种 PROTACs 的动力学溶解度和在 pH 7.4 时的分配系数(LogD),这些 PROTACs 是为了覆盖广泛的化学空间而设计和合成的。它们通常较低的溶解度和较高的亲脂性需要优化实验方法。关于 LogD,我们测试了几种预测工具,这些工具对于经典小分子非常准确,但对于 PROTACs 提供了不同的结果。最后,我们通过将内部生成的实验数据与 PROTACs 结构的 3D 描述相结合,提出了用于预测 PROTACs 动力学溶解度和 LogD 的模型。

相似文献

1
Between Theory and Practice: Computational/Experimental Integrated Approaches to Understand the Solubility and Lipophilicity of PROTACs.理论与实践之间:用于理解 PROTACs 溶解性和脂溶性的计算/实验综合方法。
J Med Chem. 2024 Sep 26;67(18):16355-16380. doi: 10.1021/acs.jmedchem.4c01235. Epub 2024 Sep 13.
2
Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications.了解蛋白水解靶向嵌合体(PROTACs)的代谢:迈向药物应用的下一步。
J Med Chem. 2020 Oct 22;63(20):11615-11638. doi: 10.1021/acs.jmedchem.0c00793. Epub 2020 Oct 7.
3
Structural and Physicochemical Features of Oral PROTACs.口服 PROTACs 的结构和物理化学特征。
J Med Chem. 2024 Aug 8;67(15):13106-13116. doi: 10.1021/acs.jmedchem.4c01017. Epub 2024 Jul 30.
4
PROTAC-DB: an online database of PROTACs.PROTAC-DB:一个 PROTAC 数据库。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1381-D1387. doi: 10.1093/nar/gkaa807.
5
Computational methods and key considerations for in silico design of proteolysis targeting chimera (PROTACs).蛋白酶靶向嵌合体(PROTACs)计算机辅助设计的计算方法及关键考量因素
Int J Biol Macromol. 2024 Oct;277(Pt 4):134293. doi: 10.1016/j.ijbiomac.2024.134293. Epub 2024 Jul 29.
6
Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment.蛋白水解靶向嵌合体(PROTACs)递送系统在肿瘤治疗中的研究进展。
Int J Biol Macromol. 2024 Aug;275(Pt 1):133680. doi: 10.1016/j.ijbiomac.2024.133680. Epub 2024 Jul 4.
7
Controlling PROTACs with Light.用光控制 PROTACs。
ChemMedChem. 2020 Jul 20;15(14):1258-1261. doi: 10.1002/cmdc.202000249. Epub 2020 Jul 2.
8
Current advances and development strategies of orally bioavailable PROTACs.口服生物可利用型 PROTACs 的最新进展与发展策略。
Eur J Med Chem. 2023 Dec 5;261:115793. doi: 10.1016/j.ejmech.2023.115793. Epub 2023 Sep 7.
9
Small-molecule PROTACs: novel agents for cancer therapy.小分子 PROTACs:癌症治疗的新型药物。
Future Med Chem. 2020 May;12(10):915-938. doi: 10.4155/fmc-2019-0340. Epub 2020 Apr 9.
10
Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.超越PROTAC的小分子降解剂——挑战与机遇
SLAS Discov. 2021 Apr;26(4):524-533. doi: 10.1177/2472555221991104. Epub 2021 Feb 25.